AN EPIDEMIOLOGIC ANALYSIS OF END-STAGE LUPUS NEPHRITIS

被引:61
作者
ISEKI, K
MIYASATO, F
OURA, T
UEHARA, H
NISHIME, K
FUKIYAMA, K
机构
[1] UNIV RYUKYUS,COMPREHENS MED RES CTR,OKINAWA,JAPAN
[2] OKINAWA PREFECTURAL NAHA HOSP,OKINAWA,JAPAN
[3] TOMISHIRO CHUO HOSP,OKINAWA,JAPAN
[4] OKINAWA CHUBU HOSP,OKINAWA,JAPAN
[5] OKINAWA KYODO HOSP,OKINAWA,JAPAN
关键词
SYSTEMIC LUPUS ERYTHEMATOSUS; MORTALITY RATE; END-STAGE LUPUS NEPHRITIS;
D O I
10.1016/S0272-6386(12)80377-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We analyzed 566 patients (515 females and 51 males) with systemic lupus erythematosus who were treated in Okinawa; Japan, from 1972 to 1991 and followed until April 1993. One hundred four patients (95 females and 9 males) died, and 51 were considered to have end-stage lupus nephritis. The annual incidence and prevalence, per million population in each sex, were increased from 16.0 and 66.0 in 1972 to 46.7 and 683.9 in 1991 in the female patients, and from 4.2 and 8.3 in 1973 to 8.3 and 70.0 in 1991 in the male patients, respectively. Cox proportional hazard analysis was done to determine the effects of several covariates on patients and renal survival. The patients' survival rate improved, as the hazard ratio (HR) was decreased to 0.69 (year of diagnosis, 1982 to 1986) and to 0.48 (year of diagnosis, 1987 to 1991) when the HR in patients diagnosed before 1981 was taken as 1.00. Similarly, we examined renal survival by using the Cox proportional model. For this analysis, the date of start of dialysis therapy was regarded as the time of renal death. Male patients had significantly poor renal survival; the HR was 3.64 (95% confidence interval, 1.89 to 6.98) when the HR in the females was taken as 1.00. However, age at diagnosis and year of diagnosis did not significantly affect renal survival. The cumulated incidence of end-stage lupus nephritis from the time of diagnosis of systemic lupus erythematosus was 3.1% at 5 years, 9.4% at 10 years, 15.5% at 15 years, and 21.0% at 20 years. The results of our study showed that there was some improvement in life expectancy, but it did not affect renal survival. Male patients had a significantly high risk of developing end-stage lupus nephritis. © 1994, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 38 条
  • [1] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS
    AUSTIN, HA
    KLIPPEL, JH
    BALOW, JE
    LERICHE, NGH
    STEINBERG, AD
    PLOTZ, PH
    DECKER, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) : 614 - 619
  • [2] SYSTEMIC LUPUS-ERYTHEMATOSUS IN PATIENTS WITH END-STAGE RENAL-DISEASE - LONG-TERM FOLLOW-UP ON THE PROGNOSIS OF PATIENTS AND THE EVOLUTION OF LUPUS ACTIVITY
    CHEIGH, JS
    KIM, H
    STENZEL, KH
    TAPIA, L
    SULLIVAN, JF
    STUBENBORD, W
    RIGGIO, RR
    RUBIN, AL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (03) : 189 - 195
  • [3] THE LONG-TERM CLINICAL COURSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN END-STAGE RENAL-DISEASE
    COPLON, NS
    DISKIN, CJ
    PETERSEN, J
    SWENSON, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (04) : 186 - 190
  • [4] WHY DO PATIENTS WITH LUPUS NEPHRITIS DIE
    CORREIA, P
    CAMERON, JS
    LIAN, JD
    HICKS, J
    OGG, CS
    WILLIAMS, DG
    CHANTLER, C
    HAYCOCK, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6462): : 126 - 131
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] IDIOPATHIC MEMBRANOUS NEPHROPATHY - THE NATURAL-HISTORY OF UNTREATED PATIENTS
    DONADIO, JV
    TORRES, VE
    VELOSA, JA
    WAGONER, RD
    HOLLEY, KE
    OKAMURA, M
    ILSTRUP, DM
    CHU, CP
    [J]. KIDNEY INTERNATIONAL, 1988, 33 (03) : 708 - 715
  • [7] ACTIVE LUPUS IN A PATIENT RECEIVING LONG-TERM HEMODIALYSIS
    FIALKOW, RZ
    RUBIN, J
    [J]. SOUTHERN MEDICAL JOURNAL, 1986, 79 (04) : 516 - 517
  • [8] FREQUENCY, ETIOLOGY, AND PREVENTION OF STROKE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    FUTRELL, N
    MILLIKAN, C
    [J]. STROKE, 1989, 20 (05) : 583 - 591
  • [9] COMPUTER-ANALYSIS OF FACTORS INFLUENCING FREQUENCY OF INFECTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    GINZLER, E
    DIAMOND, H
    KAPLAN, D
    WEINER, M
    SCHLESINGER, M
    SELEZNICK, M
    [J]. ARTHRITIS AND RHEUMATISM, 1978, 21 (01): : 37 - 44
  • [10] A MULTI-CENTER STUDY OF OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS .1. ENTRY VARIABLES AS PREDICTORS OF PROGNOSIS
    GINZLER, EM
    DIAMOND, HS
    WEINER, M
    SCHLESINGER, M
    FRIES, JF
    WASNER, C
    MEDSGER, TA
    ZIEGLER, G
    KLIPPEL, JH
    HADLER, NM
    ALBERT, DA
    HESS, EV
    SPENCERGREEN, G
    GRAYZEL, A
    WORTH, D
    HAHN, BH
    BARNETT, EV
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (06): : 601 - 611